We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$1.05B
AUM Growth
+$301M
Cap. Flow
+$299M
Cap. Flow %
28.54%
Top 10 Hldgs %
89.44%
Holding
60
New
16
Increased
3
Reduced
6
Closed
9

Top Sells

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$73M
2
RBLX icon
Roblox
RBLX
+$9.14M
3
DDOG icon
Datadog
DDOG
+$7.76M
4
NARI
Inari Medical, Inc. Common Stock
NARI
+$5.71M
5
EB
Eventbrite
EB
+$5.61M

Sector Composition

Rank Sector Weight
1 Technology 40.93%
2 Consumer Discretionary 32.4%
3 Healthcare 20.24%
4 Industrials 2.13%
5 Financials 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROOT icon
26
Root
ROOT
$972M
$2.21M 0.21%
+11,351
New +$2.15M
PATH icon
27
UiPath
PATH
$6.32B
$2.16M 0.21%
+31,830
New +$2.33M
EB
28
DELISTED
Eventbrite
EB
$2.02M 0.19%
106,064
-264,500
-71% -$5.61M
AFRM icon
29
Affirm
AFRM
$24.2B
$1.89M 0.18%
28,053
YEXT icon
30
Yext
YEXT
$564M
$1.65M 0.16%
115,147
ABCL icon
31
AbCellera Biologics
ABCL
$1.62B
$1.3M 0.12%
+59,200
New +$1.63M
MCRB icon
32
Seres Therapeutics
MCRB
$46.5M
$1.18M 0.11%
2,468
NRIX icon
33
Nurix Therapeutics
NRIX
$2.51B
$1.17M 0.11%
+44,141
New +$1.3M
ACVA icon
34
ACV Auctions
ACVA
$1.43B
$1.03M 0.1%
+40,049
New +$1.17M
CSLT
35
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$918K 0.09%
349,070
PACB icon
36
Pacific Biosciences
PACB
$432M
$821K 0.08%
23,484
DCT
37
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$631K 0.06%
14,508
CTMX icon
38
CytomX Therapeutics
CTMX
$701M
$501K 0.05%
79,193
RPTX
39
DELISTED
Repare Therapeutics
RPTX
$460K 0.04%
14,747
+2,471
+20% +$80.9K
TRVN
40
DELISTED
Trevena, Inc.
TRVN
$395K 0.04%
374
ALGS icon
41
Aligos Therapeutics
ALGS
$26.3M
$383K 0.04%
+751
New +$479K
JNCE
42
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$362K 0.03%
53,260
+33,333
+167% +$277K
BILL icon
43
BILL Holdings
BILL
$4.62B
$324K 0.03%
+1,770
New +$277K
OYST
44
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$267K 0.03%
15,545
-18,640
-55% -$354K
PMVP icon
45
PMV Pharmaceuticals
PMVP
$58.7M
$263K 0.03%
7,692
KA
46
DELISTED
Kineta, Inc. Common Stock
KA
$257K 0.02%
3,147
EPZM
47
DELISTED
Epizyme, Inc
EPZM
$205K 0.02%
24,686
METC icon
48
Ramaco Resources Class A
METC
$637M
$82K 0.01%
15,453
NXTC icon
49
NextCure
NXTC
$22.1M
$81K 0.01%
837
RAPT
50
DELISTED
RAPT Therapeutics
RAPT
$56K 0.01%
222
-1,322
-86% -$247K

Similar funds

Harbourvest Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Harbourvest Partners held 60 positions worth $1.05B, up 40% from $746M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Harbourvest Partners deployed $299M of net new capital in Q2 2021, opening 16 new positions and adding to 3 existing holdings. Its largest new stake was monday.com: 1,227,874 shares worth $275M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Roblox, an estimated $9.14M trimmed.

  • Harbourvest Partners's largest Q2 2021 buy was monday.com: 1,227,874 shares worth $275M.
  • Harbourvest Partners added most to Zuora, Inc. in Q2 2021, an estimated $2.16M increase.
  • Harbourvest Partners's biggest Q2 2021 reduction was Roblox, cutting an estimated $9.14M.
  • Harbourvest Partners fully exited Snowflake in Q2 2021, selling an estimated $73M.
  • Harbourvest Partners's ten largest holdings make up 89% of its $1.05B portfolio in Q2 2021.
  • Harbourvest Partners opened 16 new positions and closed 9 in Q2 2021.
  • Harbourvest Partners's portfolio value rose 40% quarter-over-quarter to $1.05B.

Based on Harbourvest Partners's 13F filing for Q2 2021, filed 13 Aug 2021.